Merck (MRK) Payables (2009 - 2026)
Merck (MRK) reported Payables of $6.0 billion for Q1 2026, up 2.47% year-over-year from $5.9 billion in Q1 2025, and down 8.22% on a QoQ basis from $6.5 billion in Q4 2025.
Merck (MRK) has 18 years of Payables data on file, last reported at $6.0 billion in Q1 2026.
- Quarterly Payables rose 2.47% year-over-year to $6.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.0 billion (up 2.47% YoY) and the FY2025 annual result came in at $6.5 billion, up 6.18% from the prior year.
- Payables retreated to $6.0 billion in Q1 2026 per MRK's latest filing, from $6.5 billion in the prior quarter.
- Across five years, Payables topped out at $6.5 billion in Q4 2025 and bottomed at $5.1 billion in Q3 2022.
- The 5-year median for Payables is $5.6 billion (2023), against an average of $5.7 billion.
- The widest annual swing landed in 2022, when Payables decreased 5.56%; it then increased 11.15% in 2025.
- Tracing MRK's Payables over 5 years: stood at $6.1 billion in 2022, then declined by 3.92% to $5.9 billion in 2023, then grew by 4.33% to $6.2 billion in 2024, then gained by 6.18% to $6.5 billion in 2025, then retreated by 8.22% to $6.0 billion in 2026.
- Per Business Quant, the three latest MRK Payables figures stand at $6.0 billion (Q1 2026), $6.5 billion (Q4 2025), and $6.2 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 5.03 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 27.92 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 33.77 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 6.01 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 2.94 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 645.00 Mn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 4.51 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 4.23 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 24.45 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.01 Bn |
| Dec 31, 2025 | 6.54 Bn |
| Sep 30, 2025 | 6.19 Bn |
| Jun 30, 2025 | 5.95 Bn |
| Mar 31, 2025 | 5.86 Bn |
| Dec 31, 2024 | 6.16 Bn |
| Sep 30, 2024 | 5.57 Bn |
| Jun 30, 2024 | 5.50 Bn |
| Mar 31, 2024 | 5.52 Bn |
| Dec 31, 2023 | 5.91 Bn |
| Sep 30, 2023 | 5.39 Bn |
| Jun 30, 2023 | 5.32 Bn |
| Mar 31, 2023 | 5.59 Bn |
| Dec 31, 2022 | 6.15 Bn |
| Sep 30, 2022 | 5.14 Bn |
| Jun 30, 2022 | 5.25 Bn |
| Mar 31, 2022 | 5.49 Bn |
| Dec 31, 2021 | 6.38 Bn |
| Sep 30, 2021 | 5.03 Bn |
| Jun 30, 2021 | 5.56 Bn |
| Mar 31, 2021 | 5.71 Bn |
| Dec 31, 2020 | 6.00 Bn |
| Sep 30, 2020 | 5.31 Bn |
| Jun 30, 2020 | 5.01 Bn |
| Mar 31, 2020 | 5.16 Bn |
| Dec 31, 2019 | 5.33 Bn |
| Sep 30, 2019 | 4.63 Bn |
| Jun 30, 2019 | 4.58 Bn |
| Mar 31, 2019 | 4.48 Bn |
| Dec 31, 2018 | 4.78 Bn |
| Sep 30, 2018 | 4.40 Bn |
| Jun 30, 2018 | 4.33 Bn |
| Mar 31, 2018 | 4.48 Bn |
| Dec 31, 2017 | 4.42 Bn |
| Sep 30, 2017 | 3.92 Bn |
| Jun 30, 2017 | 4.24 Bn |
| Mar 31, 2017 | 3.80 Bn |
| Dec 31, 2016 | 4.12 Bn |
| Sep 30, 2016 | 3.77 Bn |
| Jun 30, 2016 | 3.81 Bn |
| Mar 31, 2016 | 3.55 Bn |
| Dec 31, 2015 | 3.84 Bn |
| Sep 30, 2015 | 3.31 Bn |
| Jun 30, 2015 | 3.63 Bn |
| Mar 31, 2015 | 3.40 Bn |
| Dec 31, 2014 | 3.93 Bn |
| Sep 30, 2014 | 3.57 Bn |
| Jun 30, 2014 | 3.63 Bn |
| Mar 31, 2014 | 3.76 Bn |
| Dec 31, 2013 | 3.60 Bn |
| Sep 30, 2013 | 3.76 Bn |
| Jun 30, 2013 | 3.54 Bn |
| Dec 31, 2012 | 3.10 Bn |
| Jun 30, 2012 | 2.98 Bn |
| Mar 31, 2012 | 3.64 Bn |
| Dec 31, 2011 | 3.30 Bn |
| Sep 30, 2011 | 3.45 Bn |
| Jun 30, 2011 | 3.32 Bn |
| Mar 31, 2011 | 3.58 Bn |
| Dec 31, 2010 | 3.48 Bn |
| Sep 30, 2010 | 3.42 Bn |
| Jun 30, 2010 | 3.35 Bn |
| Mar 31, 2010 | 3.26 Bn |
| Dec 31, 2009 | 3.43 Bn |
| Sep 30, 2009 | 1.71 Bn |
| Jun 30, 2009 | 1.76 Bn |